Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meyling H Cheok

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Human Molecular Genetics|July 10, 2007
Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expressionNicolas Pottier, Meyling H Cheok, Wenjian Yang, et al.
Blood Advances|January 10, 2022
Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint studyAntony Ceraulo, Hélène Lapillonne, Meyling H Cheok, et al.
Plos Medicine|April 18, 2008
In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profileMichael J Sorich, Nicolas Pottier, Deqing Pei, et al.
Cancer Cell|April 20, 2005
Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemiaSanne Lugthart, Meyling H Cheok, Monique L den Boer, et al.
Journal of the National Cancer Institute|December 11, 2008
The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemiaNicolas Pottier, Wenjian Yang, Mahfoud Assem, et al.
Blood|September 29, 2005
The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemiaAmy Holleman, Monique L den Boer, Renée X de Menezes, et al.
Blood|May 20, 2006
Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocolsAmy Holleman, Monique L den Boer, Meyling H Cheok, et al.
The New England Journal of Medicine|August 6, 2004
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatmentAmy Holleman, Meyling H Cheok, Monique L den Boer, et al.
Cancers|January 8, 2020
Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex KaryotypeLaurène Fenwarth, Nicolas Duployez, Xavier Thomas, et al.
The Lancet. Oncology|January 14, 2009
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyMonique L Den Boer, Marjon van Slegtenhorst, Renée X De Menezes, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Human Molecular Genetics|July 10, 2007
Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expressionNicolas Pottier, Meyling H Cheok, Wenjian Yang, et al.
Blood Advances|January 10, 2022
Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint studyAntony Ceraulo, Hélène Lapillonne, Meyling H Cheok, et al.
Plos Medicine|April 18, 2008
In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profileMichael J Sorich, Nicolas Pottier, Deqing Pei, et al.
Cancer Cell|April 20, 2005
Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemiaSanne Lugthart, Meyling H Cheok, Monique L den Boer, et al.
Journal of the National Cancer Institute|December 11, 2008
The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemiaNicolas Pottier, Wenjian Yang, Mahfoud Assem, et al.
Blood|September 29, 2005
The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemiaAmy Holleman, Monique L den Boer, Renée X de Menezes, et al.
Blood|May 20, 2006
Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocolsAmy Holleman, Monique L den Boer, Meyling H Cheok, et al.
The New England Journal of Medicine|August 6, 2004
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatmentAmy Holleman, Meyling H Cheok, Monique L den Boer, et al.
Cancers|January 8, 2020
Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex KaryotypeLaurène Fenwarth, Nicolas Duployez, Xavier Thomas, et al.
The Lancet. Oncology|January 14, 2009
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyMonique L Den Boer, Marjon van Slegtenhorst, Renée X De Menezes, et al.
Pageof 3